Tag: EGFR,FOCAL trial,MALDi-TOF,NSCLC,Press Releases,circulating nRNA,lung cancer
-
Biodesix to Present Data on Blood Based Diagnostic Tests for Patients with Non-Small Cell Lung Cancer (NSCLC)
BOSTON– AACR-NCI-EORTC – November 6, 2015—Biodesix, Inc., today announced that its data on genomic and proteomic blood-based diagnostic assays will be presented at the 2015 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. These blood-based diagnostic tests for patients with non-small cell lung cancer (NSCLC) are developed with a focus on results…